首页> 外文OA文献 >CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus.
【2h】

CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus.

机译:接种减毒的猿猴免疫缺陷病毒疫苗后20天,CD8 +淋巴细胞不会介导针对急性超级感染的保护作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In order to test the hypothesis that CD8+ cytotoxic T lymphocytes mediate protection against acute superinfection, we depleted >99% of CD8+ lymphocytes in live attenuated simian immunodeficiency virus macC8 (SIVmacC8) vaccinees from the onset of vaccination, maintained that depletion for 20 days, and then challenged with pathogenic, wild-type SIVmacJ5. Vaccinees received 5 mg per kg of humanized anti-CD8 monoclonal antibody (MAb) 1 h before inoculation, followed by the same dose again on days 3, 7, 10, 13, and 17. On day 13, peripheral CD8+ T lymphocytes were >99% depleted in three out of four anti-CD8 MAb-treated vaccinees. At this time attenuated SIVmacC8 viral RNA loads in anti-CD8 MAb-treated vaccinees were significantly higher than control vaccinees treated contemporaneously with nonspecific human immunoglobulin. Lymphoid tissue CD8+ T lymphocyte depletion was >99% in three out of four anti-CD8 MAb-treated vaccinees on the day of wild-type SIVmacJ5 challenge. All four control vaccinees and three out of four anti-CD8 MAb-treated vaccinees were protected against detectable superinfection with wild-type SIVmacJ5. Although superinfection with wild-type SIVmacJ5 was detected at postmortem in a single anti-CD8 MAb-treated vaccinee, this did not correlate with the degree of preceding CD8+ T lymphocyte depletion. Clearance of attenuated SIVmacC8 viremia coincided with recovery of normal CD8+ T lymphocyte counts between days 48 and 76. These results support the view that cytotoxic T lymphocytes are important for host-mediated control of SIV primary viremia but do not indicate a central role in protection against acute superinfection conferred by inoculation with live attenuated SIV.
机译:为了检验CD8 +细胞毒性T淋巴细胞介导针对急性超级感染的保护这一假设,我们从接种疫苗开始就消耗了减毒的猿猴免疫缺陷病毒macC8(SIVmacC8)活疫苗中超过99%的CD8 +淋巴细胞,并维持了20天的耗尽时间,并且然后用致病的野生型SIVmacJ5攻击。疫苗接种前1小时,疫苗每公斤接受5 mg人源化抗CD8单克隆抗体(MAb),然后在第3、7、10、13和17天再次接种相同剂量的疫苗。在第13天,外周CD8 + T淋巴细胞>四抗CD8 MAb治疗的疫苗中有三分之三的细菌中有99%耗竭。此时,抗CD8 MAb治疗的疫苗中减毒的SIVmacC8病毒RNA载量明显高于同时用非特异性人免疫球蛋白治疗的对照疫苗。在野生型SIVmacJ5攻击当天,四分之三抗CD8 MAb处理的疫苗中,三分之二的淋巴组织CD8 + T淋巴细胞耗竭率> 99%。所有四种对照疫苗和四种抗CD8 MAb治疗的疫苗中的三种均受到保护,以免被野生型SIVmacJ5感染。尽管在死后在单个抗CD8 MAb处理的疫苗中检测到野生型SIVmacJ5的过度感染,但这与先前CD8 + T淋巴细胞的耗竭程度无关。减毒SIVmacC8病毒血症的清除与第48天至第76天正常CD8 + T淋巴细胞计数的恢复相吻合。这些结果支持以下观点:细胞毒性T淋巴细胞对于宿主介导的SIV原发性病毒血症的控制很重要,但并未表明在预防病毒方面发挥重要作用接种减毒活疫苗可导致急性超级感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号